García-Martín P, Alarcón-Payer C, López-Fernández E, Moratalla L, Romero A, Sainz J, et al. Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease. Ann Pharmacother. 2015;49:986–94.

Article  PubMed  Google Scholar 

Pagliuca S, Michonneau D, Sicre de Fontbrune F, Sutra Del Galy A, Xhaard A, Robin M, et al. Allogeneic reactivity-mediated endothelial cell complications after HSCT: a plea for consensual definitions. Blood Adv. 2019;3:2424–35.

Article  PubMed  PubMed Central  Google Scholar 

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, et al. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev. 2015;29:191–204.

Article  PubMed  Google Scholar 

Elfeky R, Lucchini G, Lum SH, Ottaviano G, Builes N, Nademi Z, et al. New insights into risk factors for transplant-associated thrombotic microangiopathy in pediatric HSCT. Blood Adv. 2020;4:2418–29.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Epperla N, Li A, Logan B, Fretham C, Chhabra S, Aljurf M, et al. Incidence, Risk Factors for and Outcomes of Transplant-Associated Thrombotic Microangiopathy. Br J Haematol. 2020;189:1171–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, et al. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults. Blood. 2014;124:645–53.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Oran B, Donato M, Aleman A, Hosing C, Korbling M, Detry MA, et al. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment. Biol Blood Marrow Transpl. 2007;13:469–77.

Article  CAS  Google Scholar 

Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S, et al. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2008;41:813–20.

Article  Google Scholar 

Hematopoietic Stem Cell Application Group of the Hematology Branch of the Chinese Medical Association. Chinese Expert Consensus on the Diagnosis and Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (2021 Edition). Chin J Hematol. 2021;42:177–84.

Google Scholar 

Kennedy GA, Kearey N, Bleakley S, Butler J, Mudie K, Durrant S. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange. Bone Marrow Transpl. 2010;45:699–704.

Article  CAS  Google Scholar 

Devadas SK, Toshniwal M, Bagal B, Khattry N. Successful Treatment of Transplant Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide. Indian J Hematol Blood Transfus. 2018;34:469–73.

Article  PubMed  Google Scholar 

Higham CS, Shimano KA, Melton A, Kharbanda S, Chu J, Dara J, et al. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatr Blood Cancer. 2022;69:e29641.

Article  PubMed  CAS  Google Scholar